(Q38004957)

26 August 2017

title

Bone loss in rheumatoid arthritis: systemic, periarticular, and focal (English)

1 reference

26 August 2017

1 reference

Chad Deal

1

1 reference

26 August 2017

publication date

1 June 2012

1 reference

Current Rheumatology Reports

26 August 2017

published in

1 reference

26 August 2017

volume

14

1 reference

26 August 2017

issue

3

1 reference

26 August 2017

page(s)

231-237

1 reference

https://scigraph.springernature.com/pub.10.1007/s11926-012-0253-7

26 August 2017

exact match

0 references

cites work

Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis.

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

FRAX and the assessment of fracture probability in men and women from the UK

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Impact of low-dose prednisolone on bone synthesis and resorption in early rheumatoid arthritis: experiences from a two-year randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Bone metabolism changes during anti-TNF-alpha therapy in patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Bone versus immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Osteoimmunology in rheumatic diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Mechanisms of TNF-alpha- and RANKL-mediated osteoclastogenesis and bone resorption in psoriatic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Changes in hand and generalised bone mineral density in patients with recent-onset rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Changes in hand bone mineral density and the association with the level of disease activity in patients with rheumatoid arthritis: bone mineral density measurements in a multicenter randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Estrogen deficiency and bone loss: an inflammatory tale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Up-regulation of TNF-producing T cells in the bone marrow: a key mechanism by which estrogen deficiency induces bone loss in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

The MRI view of synovitis and tenosynovitis in inflammatory arthritis: implications for diagnosis and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Bone erosions and bone marrow edema as defined by magnetic resonance imaging reflect true bone marrow inflammation in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Osteoclasts and arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Preliminary evidence for a structural benefit of the new bisphosphonate zoledronic acid in early rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Bone erosions in rheumatoid arthritis can be repaired through reduction in disease activity with conventional disease-modifying antirheumatic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Osteoblast function is compromised at sites of focal bone erosion in inflammatory arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Bone remodeling in rheumatic disease: a question of balance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Treg cells suppress osteoclast formation: a new link between the immune system and bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

Denosumab treatment effects on structural damage, bone mineral density, and bone turnover in rheumatoid arthritis: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, phase II clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11926-012-0253-7

High-sensitivity C-reactive protein and risk of nontraumatic fractures in the Bruneck study

21 January 2018

1 reference

12 December 2020

Mr Outside and Mr Inside: classic and alternative views on the pathogenesis of rheumatoid arthritis

1 reference

12 December 2020

Identification of cell types responsible for bone resorption in rheumatoid arthritis and juvenile rheumatoid arthritis

1 reference

12 December 2020

Dickkopf-1 is a master regulator of joint remodeling

1 reference

12 December 2020

Vertebral deformities in 229 female patients with rheumatoid arthritis: associations with clinical variables and bone mineral density

1 reference

12 December 2020

Effect of blockade of TNF-alpha and interleukin-1 action on bone resorption in early postmenopausal women

1 reference

12 December 2020

10.1007/S11926-012-0253-7

Identifiers

DOI

1 reference

Dimensions Publication ID

26 August 2017

1013100695

0 references

1 reference